Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)
Introduction. Intranasal drug delivery from nose-to-brain is one of the promising approaches for the treatment of brain diseases including neurodegenerative diseases, stroke, brain tumors, etc.Text. Delivery of drugs through the nose has a number of advantages, including the rapid onset of a pharmac...
Saved in:
Main Authors: | N. N. Porfiryeva, I. I. Semina, R. I. Moustafine, V. V. Khutoryanskiy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-11-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/1071 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and study of mucoadhesive microcapsules for the nasal levodopa delivery
by: D. S. Gordeeva, et al.
Published: (2024-11-01) -
Research progress on intranasal treatment for Parkinson's disease
by: Puyuan Wen, et al.
Published: (2024-06-01) -
<i>In situ</i> Intranasal Delivery Systems: Application Prospects and Main Pharmaceutical Aspects of Development (Review)
by: E. O. Bakhrushina, et al.
Published: (2021-11-01) -
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration
by: Wu H, et al.
Published: (2025-05-01) -
Intranasal and Pulmonary Lipid Nanoparticles for Gene Delivery: Turning Challenges into Opportunities
by: Tayyar Y, et al.
Published: (2025-06-01)